[HTML][HTML] Inosine mitigated diabetic peripheral neuropathy via modulating GLO1/AGEs/RAGE/NF-κB/Nrf2 and TGF-β/PKC/TRPV1 signaling pathways

NF Abdelkader, SM Ibrahim, PE Moustafa… - Biomedicine & …, 2022 - Elsevier
Inosine is a dietary supplement that is widely used for managing numerous central
neurological disorders. Interestingly, recent experimental investigation of inosine revealed …

Linagliptin attenuates the cardiac dysfunction associated with experimental sepsis in mice with pre-existing type 2 diabetes by inhibiting NF-κB

S Al Zoubi, J Chen, C Murphy, L Martin… - Frontiers in …, 2018 - frontiersin.org
The mortality rate of patients who develop sepsis-related cardiac dysfunction is high. Many
disease conditions (eg, diabetes) increase the susceptibility to infections and subsequently …

Diabetes and the cardiac dysfunction caused by experimental sepsis

SYY Al Zoubi - 2018 - qmro.qmul.ac.uk
Sepsis is the leading cause of death in ICU patients. Patients with sepsis may develop
sepsis-related cardiac dysfunction. The presence of this cardiac dysfunction can increase …

Pre-existing Type 2 Diabetes by

D Collotta, C Thiemermann - … of Organ Dysfunction in Sepsis and …, 2020 - books.google.com
Sepsis is a dysregulated body response to infection that results in life-threatening organ
dysfunction (1). The cardiovascular system is one of the important systems affected by …